Twist Bioscience is a healthcare company focusing on synthetic DNA tools, precision DNA synthesis, and sequencing technologies. In service of customers in fields such as healthcare, agriculture, industrial chemicals, and data storage, the company aims to improve lives and increase sustainability by providing innovative solutions for their clients.
Founded in 2013 in San Francisco, CA, Twist Bioscience is led by CEO Emily Marine Leproust. Since its founding, the company has grown into a medium-sized healthcare organization with 414 employees and a revenue of $203.6 million. Their innovative silicon-based DNA Synthesis Platform offers precision at a scale that is believed to be otherwise unavailable for their customers. By overcoming inefficiencies and enabling cost-effective, rapid, precise, and high-throughput synthesis and sequencing, Twist Bioscience provides both the quality and quantity of tools needed for clients to rapidly realize opportunities in their respective fields.
